SIGHT SCIENCES, INC. Financials Sight Sciences, Inc.
Equities
SGHT
US82657M1053
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.54 USD | -0.89% |
|
+7.20% | +6.78% |
| 29/04 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
| 29/04 | Sector Update: Health Care Stocks Rise in Monday Afternoon Trading | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 831.2 | 587.9 | 251.5 | 278.1 | - | - |
| Enterprise Value (EV) 1 | 603.2 | 436.2 | 147.3 | 195.1 | 219.7 | 223.9 |
| P/E ratio | -7.44 x | -6.78 x | -4.53 x | -5.59 x | -5.9 x | -8.58 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 17 x | 8.24 x | 3.1 x | 3.37 x | 2.99 x | 2.62 x |
| EV / Revenue | 12.3 x | 6.12 x | 1.82 x | 2.36 x | 2.36 x | 2.11 x |
| EV / EBITDA | -11.9 x | -5.24 x | -2.6 x | -5.33 x | -7.53 x | -11.1 x |
| EV / FCF | - | -56,70,246 x | - | - | - | - |
| FCF Yield | - | -0% | - | - | - | - |
| Price to Book | 3.59 x | 3.68 x | 2.11 x | 3.33 x | 4.58 x | 4.99 x |
| Nbr of stocks (in thousands) | 47,307 | 48,151 | 48,750 | 49,746 | - | - |
| Reference price 2 | 17.57 | 12.21 | 5.160 | 5.590 | 5.590 | 5.590 |
| Announcement Date | 24/03/22 | 13/03/23 | 07/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 48.96 | 71.33 | 81.06 | 82.54 | 92.97 | 106 |
| EBITDA 1 | - | -50.85 | -83.24 | -56.63 | -36.63 | -29.18 | -20.2 |
| EBIT 1 | - | -51.48 | -83.95 | -57.27 | -46.19 | -42.45 | -26.27 |
| Operating Margin | - | -105.15% | -117.7% | -70.66% | -55.97% | -45.67% | -24.77% |
| Earnings before Tax (EBT) 1 | - | -62.77 | -86.2 | -55.44 | -47.19 | -42.62 | -34.8 |
| Net income 1 | -34.69 | -62.96 | -86.24 | -55.55 | -47.2 | -42.63 | -34.81 |
| Net margin | - | -128.61% | -120.9% | -68.53% | -57.19% | -45.86% | -32.82% |
| EPS 2 | -3.705 | -2.360 | -1.800 | -1.140 | -1.000 | -0.9476 | -0.6518 |
| Free Cash Flow | - | - | -76.94 | - | - | - | - |
| FCF margin | - | - | -107.86% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 24/05/21 | 24/03/22 | 13/03/23 | 07/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 13.1 | 14.68 | 14.88 | 17.23 | 18.68 | 20.54 | 18.82 | 23.47 | 20.01 | 18.75 | 18.39 | 20.56 | 20.88 | 22.17 | 21.04 |
| EBITDA 1 | -13.86 | - | - | - | -21.66 | -16.9 | -17.42 | -15.04 | -13.25 | -10.92 | -11.6 | -8.3 | -8.7 | -9.3 | - |
| EBIT 1 | -14.03 | -14.72 | -22.19 | -22.86 | -21.84 | -17.05 | -17.57 | -15.19 | -13.41 | -11.11 | -14.15 | -11.35 | -10.39 | -9.448 | -14.18 |
| Operating Margin | -107.09% | -100.21% | -149.14% | -132.71% | -116.96% | -83.01% | -93.33% | -64.71% | -67.02% | -59.25% | -76.97% | -55.17% | -49.76% | -42.62% | -67.37% |
| Earnings before Tax (EBT) 1 | -17.15 | -15.84 | -23.25 | -23.83 | -22.21 | -16.9 | -17.05 | -14.75 | -12.96 | -10.68 | -14.57 | -11.81 | -10.86 | -9.987 | -15.23 |
| Net income 1 | -17.17 | -15.94 | -23.26 | -23.84 | -22.23 | -16.91 | -17.07 | -14.75 | -13.04 | -10.69 | -14.57 | -11.81 | -10.86 | -9.99 | -15.23 |
| Net margin | -131.05% | -108.52% | -156.33% | -138.39% | -119.02% | -82.3% | -90.67% | -62.86% | -65.15% | -57.02% | -79.24% | -57.44% | -51.99% | -45.06% | -72.39% |
| EPS 2 | -0.4300 | -0.3400 | -0.4900 | -0.5000 | -0.4600 | -0.3500 | -0.3500 | -0.3000 | -0.2700 | -0.2200 | -0.2892 | -0.2496 | -0.2339 | -0.2256 | -0.2767 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/11/21 | 24/03/22 | 10/05/22 | 11/08/22 | 10/11/22 | 13/03/23 | 04/05/23 | 03/08/23 | 07/11/23 | 07/03/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 228 | 152 | 104 | 83 | 58.4 | 54.2 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | -76.9 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | -87.9% | -44% | -39.6% | -40.5% | -47.6% | -53.1% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 4.890 | 3.310 | 2.450 | 1.680 | 1.220 | 1.120 |
| Cash Flow per Share | - | - | -1.590 | - | - | - | - |
| Capex | - | 0.81 | 0.97 | - | - | - | - |
| Capex / Sales | - | 1.66% | 1.36% | - | - | - | - |
| Announcement Date | 24/05/21 | 24/03/22 | 13/03/23 | 07/03/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
5.59
USD
Average target price
5.625
USD
Spread / Average Target
+0.63%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.78% | 278M | |
| -4.38% | 184B | |
| -2.26% | 107B | |
| -4.04% | 67.52B | |
| +1.14% | 50.06B | |
| +9.92% | 45.67B | |
| +3.40% | 41B | |
| +3.20% | 26.73B | |
| +3.82% | 26.47B | |
| +15.23% | 25.05B |
- Stock Market
- Equities
- SGHT Stock
- Financials Sight Sciences, Inc.
